COMETE Study : COgnitive Rehabilitation of MEmory in Temporal Epilepsy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-03-03

Study Completion Date

2021-01-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Studies on the cognitive function have highlighted promising results concerning attention. In contrast, in the field of memory, the single cohort study that has been carried out, has not been randomised, with non comparable groups, the significant outcomes are therefore to be balanced.

In this study, patients with focal and structural temporal lobe epilepsy will be randomised in 2 groups : the COMETE group where patients will attend a specific rehabilitation programme of memory and the control group where patients will benefit from a standard treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Spatial Memory and Temporal Lobe Epilepsy

NCT06847152

Epilepsy Lobe Temporal Healthy Epilepsy

RECRUITING NA

Cogmed for Working Memory After TBI

NCT02305212

Traumatic Brain Injury

COMPLETED NA

Attention/Working Memory Rehabilitation in Multiple Sclerosis: A Pilot Project Using Cogmed Working Memory Training

NCT02634567

Multiple Sclerosis

COMPLETED NA

Cognitive Rehabilitation of Working Memory After Moderate to Severe Traumatic Brain Injury

NCT03874416

Moderate to Severe Traumatic Brain Injury

UNKNOWN NA

Cognitive Remediation on Patients With Bipolar Disorder and Memory Complaints

NCT02988518

Patient With Bipolar Disorder Euthymic Status Wirh Memory Complaints

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Epilepsy is a chronic neurological disease among the most frequent ones. It causes cognitive disorders in 20 to 50 percent of patients with structural epilepsy, that is to say in connexion with an identified or presumed cerebral lesion. Compared to seizures, these cognitive disorders are a major additional factor of professional, social or family disability. They are particularly prevalent (50%) in temporal lobe epilepsy and preferentially affect language memory and abilities. These disorders are well described, they are multifactorial but no (drug and/or non drug) therapy has been validated yet.

Recently, techniques of cognitive rehabilitation have shown benefits in some neurological diseases, like multiple sclerosis.

Concerning adulthood epilepsy, the few cognitive rehabilitation studies that have been conducted present huge methodological gaps limiting the scope of theirs results.

Studies on the cognitive function have highlighted promising results concerning attention. In contrast, in the field of memory, the single cohort study that has been carried out, has not been randomised, with non comparable groups, the significant outcomes are therefore to be balanced.

Thus, in this study, patients with focal and structural temporal lobe epilepsy will be randomised in 2 groups : the COMETE group where patients will attend a specific rehabilitation programme of memory and the control group where patients will benefit from a standard treatment.

Work's hypothesis would be that patients undergoing the rehabilitation programme would present improved learning abilities (with impact on their memory performances) compared to patients with standard treatment.

This hypothesis is based on underlying theories of cognitive rehabilitation. This method predicts that by reinforcing some cognitive abilities that transfer to others, the improved learning abilities will also result in improved abilities in immediate memory, work memory, but will have no effect on verbal inhibition abilities, which will constitute a specific marker/indicator ? for the intervention. Moreover, patient care may have an impact on their quality of life and mood which are predictive factors for a good social and professional integration: that's why these indexes/criteria have to be measured.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Epilepsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

COMETE

patients will attend a specific rehabilitation programme of memory

Group Type EXPERIMENTAL

COMETE

Intervention Type OTHER

Patients of COMETE group will attend 12 individual sessions of cognitive rehabilitation, which are not systematic in usual treatment, and will receive memory exercises via internet to continue cognitive exercizes at home.

CONTROL

the control group where patients will benefit from a standard treatment

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

COMETE

Patients of COMETE group will attend 12 individual sessions of cognitive rehabilitation, which are not systematic in usual treatment, and will receive memory exercises via internet to continue cognitive exercizes at home.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults with structural temporal lobe epilepsy, according to Fischer et al (2005) criteria.
* Patients aged 18-70
* Patients with epilepsy for more than 2 year
* Patients with mild to severe memory impairment (minimum score : -1,6σ / average at Buschke Reminding Test, learning index
* Patients with equal or higher Intellectual Quotient than 70 (WAIS-IV)
* stabilized anti epileptic treatment (same treatment for the last 6 months)
* Patient who has given informed consent in writing
* Patients with social insurance
* Patients with internet connexion for weekly training at home

Exclusion Criteria

* other progressive associated neurological (history of stroke for example) or psychiatric disease
* temporal lobe surgery within following 12 months
* presence of a progressive brain lesion
* legally protected adults or adults incapable of giving informed consent
* persons who are deprived of their liberty by judicial or administrative decision

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No